Table 2– Adverse clinical outcome in the 3-month follow-up period
Clinical outcomeAll PE patients#PE patients treated as outpatientsPE patients treated as in-patients#p-value
Subjects n526297229
Total recurrences15 (2.9)6 (2.0)9 (3.9)0.290
 Fatal recurrent PE5 (1.0)05 (2.2)0.015
 Nonfatal recurrent PE9 (1.7)5 (1.7)4 (1.7)1.000
 Nonfatal recurrent DVT1 (0.2)1 (0.3)01.000
Major bleeding13 (2.5)2 (0.7)11 (4.8)0.003
Fatal bleeding2 (0.4)1 (0.3)1 (0.4)1.000
All-cause mortality25 (4.8)3 (1.0)22 (9.6)<0.001
  • Data are presented as n (%), unless otherwise stated. PE: pulmonary embolism; DVT: deep vein thrombosis. #: four in-patients were lost-to-follow-up; : in-patients versus outpatients.